References
- Parkes, Bisriop and Dodds. Oestrin and cancer. Lancet 1936; 2: 1365
- Schiff I., Komarov S. H., Cramer D., Tulchin-sky D., Ryan K. J. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil. Steril. 1982; 37: 79–82
- Hunt K. J. R. Coll. Gen. Pract. 1988; 38: 398–401
- Cooper C., Barrett-Connor E. The incidence of osteoporosis: epidemiology. Proceedings of the 1996 World Congress on Osteoporosis, P. L. Papapoulos, P. Lips, H. A. Pols, C. C. Johnston, P. D. Delmas. Elsevier, Amsterdam 1996; 75–7, 18-23 May
- Melton L. J., III. Global aspects of osteoporosis: epidemiology. Proceedings of the 1996 World Congress of Osteoporosis, P. L. Papapoulos, P. Lips, H. A. Pols, C. C. Johnston, P. D. Delmas. Elsevier, Amsterdam 1996; 79–86, Amsterdam, 18-23 May
- Maxim P., Ettinger B., Spitalny G. M. Fracture protection provided by long-term hormone replacement therapy. Osteoporosis Int. 1995; 5: 23–9
- Tax L., Goorissen E. M., Kicovic P. M. Clinical profile of Org OD 14. Maturitas 1987, Suppl. 1: 3–13
- Lindsay R., Hart D. M., Kraszewski A. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br. J. Med. 1980; 280: 1207–9
- Fentiman I. S. Pregnancy and exogenous estrogens. The Diagnosis and Treatment of Early Breast Cancer. , I. S. Fentiman. Martin Dunitz, London 1993
- Sullivan J. M. Atherosclerosis and estrogen replacement therapy. Int. J. Fertil 1994; 39: 28–35